DGX (Quest Diagnostics Inc.) Stock Analysis - Politician Trades

Quest Diagnostics Inc. (DGX) is a publicly traded Healthcare sector company. As of May 21, 2026, DGX trades at $193.75 with a market cap of $21.01B and a P/E ratio of 21.18. DGX moved +2.02% today. Year to date, DGX is +11.68%; over the trailing twelve months it is +8.70%. Its 52-week range spans $146.17 to $213.50. Analyst consensus is buy with an average price target of $220.50. Rallies surfaces DGX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded DGX stock?

Recent politician trading activity in DGX includes disclosures from Julie Johnson, Carol Devine Miller, Gil Cisneros, Ro Khanna, and Earl Blumenauer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

DGX Key Metrics

Key financial metrics for DGX
MetricValue
Price$193.75
Market Cap$21.01B
P/E Ratio21.18
EPS$9.17
Dividend Yield0.86%
52-Week High$213.50
52-Week Low$146.17
Volume0
Avg Volume0
Revenue (TTM)$11.28B
Net Income$1.07B
Gross Margin33.20%

Congressional Trades in DGX

  • Julie Johnson sale DGX on Nov 3, 2025 (amount: $15.00K) for Joint.
  • Carol Devine Miller sale (full) DGX on Mar 10, 2025 (amount: $15.00K).
  • Gil Cisneros sale DGX on Jan 24, 2025 (amount: $15.00K).
  • Ro Khanna purchase DGX on Nov 15, 2024 (amount: $15.00K).
  • Earl Blumenauer sale (full) DGX on Apr 4, 2024 (amount: $15.00K) for Spouse.

Latest DGX News

Recent DGX Insider Trades

  • Doherty Catherine T. sold 5.56K (~$1.15M) on Mar 5, 2026.
  • PREVOZNIK MICHAEL E sold 3.88K (~$799.68K) on Mar 5, 2026.
  • Plewman Patrick sold 2.85K (~$588.73K) on Mar 5, 2026.

DGX Analyst Consensus

9 analysts cover DGX: 0 strong buy, 4 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $220.50.

Common questions about DGX

Which politicians traded DGX stock?
Recent politician trading activity in DGX includes disclosures from Julie Johnson, Carol Devine Miller, Gil Cisneros, Ro Khanna, and Earl Blumenauer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in DGX?
Yes. Rallies tracks politician and congressional stock disclosures for DGX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is DGX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for DGX. It does not provide personalized investment advice.
DGX

DGX